Company intelligence / Profile preview

MED-EL

Innsbruck, Tyrol, Austriamedel.com ↗

Ownership: Private
Employees: ~2300
Development stage: Commercial

Overview

MED-EL’s cochlear and other implantable devices are widely used globally with over 200,000 users. The company’s products are approved for a broad range of indications including single-sided deafness in adults and children. Clinical results demonstrate improved speech understanding and quality of life for recipients[1][2][5].

Therapeutic areas: OtherNeurology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Collaborations with academic institutions globally; no major pharma partnerships reported[5]

Beyond the preview

Go deeper on MED-EL.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MED-EL.

Explore the full profile